| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NTLA | Intellia Therapeutics, Inc. | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | Jan 08, 2024 | Sale | $28.87 | 2,275 | 65,682 | 44,594 | Jan 10, 2024, 04:15 PM | |
| NTLA | Intellia Therapeutics, Inc. | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | Jan 03, 2024 | Sale | $29.46 | 5,532 | 162,973 | 46,202 | Jan 05, 2024, 04:50 PM | |
| NTLA | Intellia Therapeutics, Inc. | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | Jan 05, 2023 | Sale | $38.48 | 2,330 | 89,659 | 18,318 | Jan 06, 2023, 05:39 PM | |
| NTLA | Intellia Therapeutics, Inc. | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | Jan 04, 2023 | Sale | $37.21 | 2,508 | 93,323 | 19,959 | Jan 06, 2023, 05:39 PM | |
| NTLA | Intellia Therapeutics, Inc. | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | Jan 01, 2022 | Sale | $112.25 | 1,148 | 128,863 | 4,815 | Mar 03, 2022, 08:03 PM | |
| NTLA | Intellia Therapeutics, Inc. | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | Aug 30, 2021 | Option Exercise | $14.01 | 97,000 | 1,359,300 | 99,391 | Sep 01, 2021, 07:34 PM | |
| NTLA | Intellia Therapeutics, Inc. | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | Aug 30, 2021 | Sale | $154.83 | 97,000 | 15,018,055 | 83,552 | Sep 01, 2021, 07:34 PM | |
| NTLA | Intellia Therapeutics, Inc. | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | Aug 04, 2021 | Sale | $138.24 | 26,000 | 3,594,357 | 26,920 | Aug 06, 2021, 06:19 PM | |
| NTLA | Intellia Therapeutics, Inc. | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | Aug 04, 2021 | Option Exercise | $13.40 | 26,000 | 348,400 | 28,391 | Aug 06, 2021, 06:19 PM |
Menu